BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vaccines

Amyris Announces JV Partnership With ImmunityBio For Next Generation COVID-19 RNA Vaccine

The parties have signed a binding term sheet, and a definitive agreement is in process and is expected to be executed within the next month pending standar...

November 09, 2021 | News

Novavax Files COVID-19 Vaccine for EU Listing with WHO

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

November 05, 2021 | News

Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand

All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for Medsafe Novavax, Inc. (Nasdaq: NVAX), a biote...

November 04, 2021 | News

Novavax and Serum Institute of India Receive EUA for COVID-19 Vaccine in Indonesia

"The first authorization of Novavax' COVID-19 vaccine exemplifies our commitment to equitable global access and will fill a vital need for Indonesia, ...

November 02, 2021 | News

Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia

-- Application marks the first protein-based COVID-19 vaccine submitted to regulatory authorities for provisional approval in Australia --...

November 01, 2021 | News

Why is the WHO delaying an EUL status to Covaxin?

The World Health Organisation usually takes around 6 to 9 weeks to analyse the data submitted by a vaccine manufacturer and then takes a call on whether to...

October 30, 2021 | Opinion | By "Akhil Pathak , an independent writer who keeps an eye on issues related to health, education, society, global politics and defence. He also follows the geo-strategic matters that are directly or indirectly related to the security framework of India."

Hanmi Science Consortium Drives Ambitious Project for Worldwide Vaccine Equity

Hanmi Science doesn't just want the world to know they are committed to vaccine equity, they want to prove it. Mr. Lim, CEO of Hanmi Science, echoes the co...

October 29, 2021 | News

Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom

All modules required for regulatory review, including CMC data, are now complete Submission based on Phase 3 data from ~45K patients demonstrating high ...

October 28, 2021 | News

Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines

The announcement by WHO, comes after the approval from WHO Ethics Review Committee and relevant regulatory authorities and ethics committees of&n...

October 27, 2021 | News

Korean Ginseng Research Institute Announces potential COVID-19 Vaccine Adjuvant Effect of Red Ginseng

The results of the study summarized this time showed that red ginseng increased the effectiveness of the vaccine, so that when red ginseng was taken togeth...

October 22, 2021 | News

Elixirgen Therapeutics Announces Licensing Agreement for Its Novel COVID-19 Vaccine

it has entered into an exclusive licensing agreement with a global pharmaceutical company (currently undisclosed) for the rights to commercialize its self-...

October 11, 2021 | News

Novavax and Serum Announce Submission to WHO for EU Listing of Novavax

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, w...

September 24, 2021 | News

DHL delivers 1 billion COVID-19 vaccine doses

• 1 billion vaccine doses shipped to more than 160 countries in the fight against COVID-19 since December 2020• Smooth management and execution o...

September 17, 2021 | News

Everest Medicines to Advance mRNA Vaccines in Emerging Markets in Asia

Providence grants Everest license to develop and market potentially "Best-In-Class" mRNA COVID-19vaccine for select Asia territories Provid...

September 15, 2021 | News

Stay Connected